Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Alzheimer disease”

Longitudinal Early-onset Alzheimer's Disease Study ProtocolActive Not Recruiting
NCT03507257N/AUpdated Jul 29, 2026
Sponsor: Indiana University
Early Onset Alzheimer Disease · Alzheimer Disease · Mild Cognitive Impairment
United States, Argentina, Netherlands, Spain, Sweden +1 more
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseRecruiting
NCT07011745Phase 3Updated Jul 29, 2026
Sponsor: Bristol-Myers Squibb
Alzheimer's Disease
United States, Argentina, Chile, Czechia, France +9 more
Technology and Family Thriving StudyCompleted
NCT05150990NAUpdated Jul 29, 2026
Sponsor: University of California, Santa Barbara
Alzheimer Disease · Dementia · Caregiver Burnout · Quality of Life
United States
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's DiseaseCompleted
NCT04520698NAUpdated Jul 29, 2026
Sponsor: Indiana University
Alzheimer Disease
United States
Levetiracetam for Persons at Risk for Alzheimer's DiseaseRecruiting
NCT07477431Phase 2Updated Jul 29, 2026
Sponsor: Sunnybrook Health Sciences Centre
Hippocampal Hyperactivation · Prodromal Alzheimer Disease
Canada
Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk FactorsRecruiting
NCT07731191NAUpdated Jul 28, 2026
Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli
Mild Cognitive Impairment (MCI) · Subjective Cognitive Decline (SCD)
Italy
Supplementing Neuro-Energy to Aid CognitionNot Yet Recruiting
NCT06767124NAUpdated Jul 28, 2026
Sponsor: University of Pennsylvania
Alzheimer Disease and Related Dementias (ADRD)
Canada
Phase 1 Study of OLX-07010 in Healthy Adult and Elderly ParticipantsActive Not Recruiting
NCT05696483Phase 1Updated Jul 28, 2026
Sponsor: Oligomerix, Inc
Alzheimer Disease
United States
PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 CarriersNot Yet Recruiting
NCT07730671N/AUpdated Jul 28, 2026
Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Subjective Cognitive Decline (SCD)
Spain
Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's DiseaseEnrolling By Invitation
NCT07694921NAUpdated Jul 27, 2026
Sponsor: First Affiliated Hospital of Zhejiang University
Alzheimer's Disease(AD)
China
Ozanimod in Patients With Alzheimer's DiseaseRecruiting
NCT06862960Phase 2Updated Jul 27, 2026
Sponsor: ChenXiaoChun
Alzheimer Disease
China
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Active Not Recruiting
NCT05269394Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +11 more
Community-based Brain Health Program to Address Dementia RiskCompleted
NCT05529706NAUpdated Jul 27, 2026
Sponsor: Posit Science Corporation
Dementia · Alzheimer Disease
United States
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting
NCT06647498Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001Active Not Recruiting
NCT01760005Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +10 more
COMMETS- Combination MCI Metabolic SyndromeRecruiting
NCT06072963Phase 2Updated Jul 27, 2026
Sponsor: Rutgers, The State University of New Jersey
Alzheimer Disease · Mild Cognitive Impairment · Metabolic Syndrome
Israel
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting
NCT05552157Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's DiseaseActive Not Recruiting
NCT06384573Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimer's Disease · Dementia · Alzheimer's Disease, Familial
United States, Australia, United Kingdom
ACP-204 in Adults With Alzheimer's Disease PsychosisRecruiting
NCT06159673Phase 2, Phase 3Updated Jul 24, 2026
Sponsor: ACADIA Pharmaceuticals Inc.
Alzheimer's Disease Psychosis
United States, Brazil, Bulgaria, Chile, Czechia +7 more
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's TypeRecruiting
NCT06052254Phase 2Updated Jul 24, 2026
Sponsor: Teikoku Pharma USA, Inc.
Agitation
United States
Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application TrialRecruiting
NCT07213284NAUpdated Jul 24, 2026
Sponsor: Michigan State University
Pregnancy · Pregnancy, Complications · Pregnancy Outcomes
United States
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)Completed
NCT04867616Phase 2Updated Jul 24, 2026
Sponsor: UCB Biopharma SRL
Alzheimer's Disease
United States, Belgium, Canada, France, Germany +5 more
Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's DiseaseCompleted
NCT02947893Phase 2Updated Jul 23, 2026
Sponsor: Georgetown University
Alzheimer's Disease
United States
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's DiseaseRecruiting
NCT07724132Phase 3Updated Jul 23, 2026
Sponsor: University College, London
Alzheimer's Disease (AD) · Mild Cognitive Impairment Due to Alzheimer's Disease · Alzheimer Disease Dementia
United Kingdom
Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family CaregiversRecruiting
NCT07721701N/AUpdated Jul 23, 2026
Sponsor: University of Erlangen-Nürnberg Medical School
Mild Cognitive Disorder · Alzheimer Disease · Vascular Dementia · Dementia in Other Diseases Classified Elsewhere
Germany

Previous page Next page